UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Neuromuscular disorders : NMD, ISSN 0960-8966, 10/2019, Volume 29, pp. S136 - S137
Journal Article
ISSN 1744-683X, 2/2014, Volume 1, Issue 9, pp. 1325 - 1328
Journal Article
Canadian journal of cardiology, ISSN 0828-282X, 2014, Volume 30, Issue 10, pp. S297 - S297
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 4/2014, Volume 344, Issue 6182, pp. 413 - 415
Transcriptomes | RNA | Gene frequency | Genetic variation | REPORTS | Alleles | Genomes | Nucleic acids | Methylation | Sequencing | Transfer RNA | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Humans | Middle Aged | Transcriptome | Male | Mutation, Missense | RNA - genetics | Genetic Variation | Ribonuclease P - genetics | Ribonuclease P - metabolism | DNA, Mitochondrial - genetics | Base Sequence | RNA, Transfer - genetics | Adult | Female | RNA, Transfer - chemistry | DNA, Mitochondrial - chemistry | RNA - metabolism | Genome-Wide Association Study | RNA Processing, Post-Transcriptional | RNA, Transfer - metabolism | RNA - chemistry | Sequence Analysis, DNA | Sequence Analysis, RNA | Aged | High-Throughput Nucleotide Sequencing | Polymorphism, Single Nucleotide | Genome, Mitochondrial | RNA sequencing | Genetic research | Research | Mitochondria | Mutation | Ribonucleic acid--RNA | Genomics | Index Medicus
Journal Article
Cancer discovery, ISSN 2159-8274, 03/2017, Volume 7, Issue 3, pp. 302 - 321
Life Sciences & Biomedicine | Oncology | Science & Technology | Epigenesis, Genetic | Humans | Positive Transcriptional Elongation Factor B - antagonists & inhibitors | Discoidin Domain Receptor 1 - genetics | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Positive Transcriptional Elongation Factor B - metabolism | Molecular Targeted Therapy | Positive Transcriptional Elongation Factor B - genetics | Triple Negative Breast Neoplasms - drug therapy | Heterocyclic Compounds, 4 or More Rings - pharmacology | DNA Methylation | Heterocyclic Compounds, 4 or More Rings - therapeutic use | RNA Interference | Triple Negative Breast Neoplasms - pathology | Female | Pyrimidinones - pharmacology | Antineoplastic Agents - pharmacology | Triazoles - therapeutic use | MAP Kinase Kinase 1 - antagonists & inhibitors | Pyrimidinones - therapeutic use | Transcription Factors - antagonists & inhibitors | Mice, SCID | Azepines - therapeutic use | Azepines - pharmacology | Drug Synergism | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Enhancer Elements, Genetic | MAP Kinase Kinase 2 - antagonists & inhibitors | Triple Negative Breast Neoplasms - metabolism | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice, Inbred BALB C | Pyridones - therapeutic use | Pyridones - pharmacology | Index Medicus
Journal Article
Recherches sociographiques, ISSN 0034-1282, 2015, Volume 56, Issue 2-3, p. 505
Journal Article
Journal of oral rehabilitation, ISSN 0305-182X, 2014, Volume 41, Issue 1, pp. 2 - 23
diagnosis | musculoskeletal pain | temporomandibular joint disorders | taxonomy | temporomandibular disorders | Temporomandibular disorders | Musculoskeletal pain | Diagnosis | Temporomandibular joint disorders | Taxonomy | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Headache - etiology | Temporomandibular Joint Disorders - classification | Humans | Terminology as Topic | Male | Temporomandibular Joint Disorders - diagnosis | Consensus | Information Dissemination | Temporomandibular Joint Disorders - complications | Reference Standards | Temporomandibular Joint Disorders - physiopathology | Range of Motion, Articular | Female | Facial Pain - etiology | Pain Measurement | Practice Guidelines as Topic | Index Medicus | Dentistry | Temporomandibular Joint Disorders | Medicine | ODONTOLOGY | ODONTOLOGI
Journal Article
Biocontrol science and technology, ISSN 0958-3157, 03/2007, Volume 17, Issue 3, pp. 261 - 272
Journal Article
Bulletin d'histoire politique, ISSN 1201-0421, 2014, Volume 22, Issue 3, p. 338
Journal Article
AIDS (London), ISSN 0269-9370, 2010, Volume 24, Issue 1, pp. 123 - 137
Inverse probability weighting | Marginal structural models | HIV infection | Mortality | Antiretroviral therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | United States - epidemiology | Antiretroviral Therapy, Highly Active - mortality | Drug Administration Schedule | Humans | Middle Aged | Proportional Hazards Models | Europe - epidemiology | Male | CD4 Lymphocyte Count | Viral Load | Drug Therapy, Combination - mortality | Time Factors | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Prognosis | antiretroviral agents | Acquired immune deficiency syndrome | antiretroviral therapy | CD4 antigen | Index Medicus | AIDS/HIV | mortality | marginal structural models | inverse probability weighting
Journal Article
Documentation et bibliothèques, ISSN 0315-2340, 2013, Volume 59, Issue 2, p. 127
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2011, Volume 154, Issue 8, pp. 509 - 515
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Anti-Retroviral Agents - therapeutic use | Prospective Studies | Drug Administration Schedule | Humans | Proportional Hazards Models | CD4 Lymphocyte Count | Acquired Immunodeficiency Syndrome - drug therapy | Cause of Death | Disease Progression | Acquired Immunodeficiency Syndrome - immunology | HIV Infections - immunology | Developed Countries | Anti-Retroviral Agents - administration & dosage | Acquired Immunodeficiency Syndrome - mortality | Observation | HIV Infections - drug therapy | HIV Infections - mortality | Drug Therapy, Combination | Mortality | AIDS (Disease) | Research | Drug therapy | HIV infection | Health aspects | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Industrialized nations | Index Medicus | Abridged Index Medicus | HIV Infections | Anti-Retroviral Agents | Life Sciences | Human health and pathology | Acquired Immunodeficiency Syndrome
Journal Article
Cell cycle (Georgetown, Tex.), ISSN 1538-4101, 04/2017, Volume 16, Issue 8, pp. 731 - 732
Journal Article
2019, Document de recherche (Secrétariat canadien de consultation scientifique), Volume 2019/008., 1 ressource en ligne (viii, 61 pages)
eBook
2019, Research Document (Canadian Science Advisory Secretariat), Volume 2019/008., 1 online resource (viii, 59 pages)
eBook